US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Dova Pharmaceuticals Inc.

28.04

0.0000

Volume:- -

Turnover:- -

Market Cap:807.60M

PE:-10.95

High:28.04

Open:28.04

Low:28.04

Close:28.04

52wk High:28.54

52wk Low:5.62

Shares:28.80M

Float Shares:9.34M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5607

EPS(LYR):-2.5998

ROE:-90.08%

ROA:-39.36%

PB:15.90

PE(LYR):-10.79

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Dova Pharmaceuticals Inc.

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.dova.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Dova Pharmaceuticals, Inc., a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia diseases. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist that has completed Phase III clinical trials for the treatment of thrombocytopenia in patients with chronic liver diseases. The company was founded in 2016 and is based in Durham, North Carolina.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DOVA/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DOVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DOVA\",,,,,undefined,":{"symbol":"DOVA","market":"US","secType":"STK","nameCN":"Dova Pharmaceuticals Inc.","latestPrice":28.04,"timestamp":1573506000000,"preClose":28.04,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":9338364,"shares":28801863,"eps":-2.560714,"marketStatus":"Halted","change":0,"latestTime":"11-11 16:00:00 EST","open":28.04,"high":28.04,"low":28.04,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.560714,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770800400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1498708800000,"exchange":"NASDAQ","adjPreClose":28.04,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DOVA\",,,,,undefined,":{"symbol":"DOVA","floatShares":9338364,"roa":"-39.36%","roe":"-90.08%","lyrEps":-2.599775,"shares":28801863,"dividePrice":0,"high":28.04,"amplitude":0,"preClose":28.04,"low":28.04,"week52Low":5.62,"pbRate":"15.90","week52High":28.54,"institutionHeld":0,"latestPrice":28.04,"eps":-2.560714,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.560714,"open":28.04,"prevYearClose":28.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DOVA\",params:#limit:5,,,undefined,":[{"date":"2019-08-06","symbol":"DOVA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.57,"defaultRemindTime":1565078400000,"name":null,"time":"Pre-Market","dateTimestamp":1565064000000,"actualEps":-0.7},{"market":"US","date":"2019-03-05","symbol":"DOVA","fiscalQuarterEnding":"2018/12","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1551762000000,"reportTimeType":"pre","actualEps":-0.69},{"market":"US","date":"2018-11-08","symbol":"DOVA","fiscalQuarterEnding":"2018/09","expectedEps":-0.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"post","actualEps":-0.69},{"market":"US","date":"2018-08-09","symbol":"DOVA","fiscalQuarterEnding":"2018/06","expectedEps":-0.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1533787200000,"reportTimeType":"post","actualEps":-0.7},{"market":"US","date":"2018-05-09","symbol":"DOVA","fiscalQuarterEnding":"2018/03","expectedEps":-0.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1525838400000,"reportTimeType":"post","actualEps":-0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DOVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DOVA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.dova.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Dova Pharmaceuticals, Inc., a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia diseases. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist that has completed Phase III clinical trials for the treatment of thrombocytopenia in patients with chronic liver diseases. The company was founded in 2016 and is based in Durham, North Carolina.","exchange":"NASDAQ","name":"Dova Pharmaceuticals Inc.","nameEN":"Dova Pharmaceuticals Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"DOVA\",market:\"US\",,,undefined,":null}}